Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02236650 · ClinicalTrials.gov registry record · NA
Primary Care Stepping Stones Triple P for Children With Autism
A NA study, sponsored by St. Louis University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02236650: Completed NA study, sponsored by St. Louis University.
NCT02236650 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02236650, a NA study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of Primary Care Stepping Stones Triple P (PC-SS Triple P), an empirically supported parent mediated intervention, to improve the behavioral functioning of children newly diagnosed with Autism (aged 2-12 years), increase parental resilience and decrease parental stress.
Primary Outcome
Measure conduct problem behavior in children between the ages of 2 and 16 years.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Primary Care Stepping Stones Triple P (PC-SS Triple P)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02236650 record still lists
NCT02236650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT02236650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02236650 about?
NCT02236650 is a clinical study titled "Primary Care Stepping Stones Triple P for Children With Autism". The purpose of this study is to determine the effectiveness of Primary Care Stepping Stones Triple P (PC-SS Triple P), an empirically supported parent mediated intervention, to improve the behavioral functioning of children newly diagnosed with Autism (aged 2-12 years), increase parental resilience ...
What is the current status of trial NCT02236650?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02236650?
The interventions under investigation include: Treatment as Usual (OTHER), Primary Care Stepping Stones Triple P (PC-SS Triple P) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02236650?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02236650's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia